The abstract is read at the publisher; the summary is JClub's.
In the prospective BoHemE study, patients with myelodysplastic neoplasms (n=111) had lower baseline bone mineral density T-scores than age-matched controls, especially in women.
- Why it matters: Bone health in MDS has lacked prospective longitudinal evaluation, despite marrow and microenvironment alterations that could affect skeletal status and outcomes.
- What they did: Bone mineral density T-scores and bone-specific serum markers were measured at baseline and after 3 years in BoHemE patients with MDS and age-matched controls, with correlations to albumin-adjusted calcium and phosphate and analysis by DNMT3A status.
- The result: Over 3 years, T-scores declined in MDS (−0.3; p<0.05), and osteoporosis was linked to poorer overall survival (p<0.01), supporting bone assessment in MDS care.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.